Molecular weight:473.584 g/mol
Raloxifene,can stimulate target sites in bone tissue.Raloxifene is therefore used to maintain or increase bone density and thereby reduce the occurrence of fractures in post-menopausal women (or younger women without ovaries) who are at risk of osteoporosis or in whom osteoporosis is established.Raloxifene is also binds to oestrogen target sites on the breast but in this case it blocks stimulation of breast tissue by oestrogen (a means by which many breast cancers develop).
For more information OR other specifications of the products, please contact us.
Disclaimer: The information on this website is from the internet for reference only. Please refer to the actual instructions attached to the product and the final interpretation is owned by the company.
Send Enquiry Online
For more information OR other products. Please contact us by Email, Tel, Fax or Send online enquiry. We will reply you as soon as possible.
1. E-mail: firstname.lastname@example.org
2. Tel: +86 592 536 5868
3. WhatsApp: +86 189 6516 2351